HERANTIS PHARMA OYJ
502098-0412ActiveDeveloping disease-modifying therapies for Parkinson's disease progression.
Oversikt
- 0
- Ansatte
- Ukjent
- Omsetning
- 2025
- Grunnlagt
Nøkkelbeslutningstakere
Tone Kvåle
Chief Financial Officer
Henri Huttunen
Chief Scientific Officer
Timo Veromaa
Chairman of the Board
Hilde Furberg
Board Member
+4 flere kontakter i Funnelfeedr
Beskrivelse
Herantis Pharma Plc is a clinical-stage biotechnology company dedicated to addressing the unmet medical need in neurodegenerative diseases. Their primary focus is developing disease-modifying therapies aimed at stopping or reversing disease progression, specifically targeting Parkinson's disease. Th...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- Utländsk juridisk person
- MVA-nummer
- SE502098041201
Beslutningstakere
8 kontakter i FunnelfeedrTone Kvåle
Chief Financial Officer
Henri Huttunen
Chief Scientific Officer
Timo Veromaa
Chairman of the Board
Hilde Furberg
Board Member
Antti Vuolanto
Chief Executive Officer
Aki Prihti
Board Member
Frans Wuite
Board Member
Mats Thorén
Board member
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrHMNC HOLDING GMBH
1–4 ansattePioneering precision psychiatry treatments using AI for mental health.
Grespo AB
0 ansatteYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Polku Therapeutics Oy
Developing novel therapies for debilitating neurodegenerative diseases.
ScandiBio Therapeutics AB
0 ansatteAI-driven biotechnology company developing drugs targeting mitochondrial dysfunction.
Egetis Therapeutics AB (publ)
20–49 ansatteInnovative pharmaceutical company developing late-stage orphan drug treatments.
Utforsk mer
Spørsmål om HERANTIS PHARMA OYJ
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo